Artemether with lumefantrine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Artemether with lumefantrine and local guidelines before prescribing.
Mechanism
Artemisinin free-radical damage plus haem-polymerisation inhibition.
Uses
Uncomplicated falciparum malaria.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Headache, dizziness, palpitations, QT prolongation, nausea.
Interactions
QT-prolonging drugs; CYP3A4 inducers and inhibitors.
Contraindications and cautions
QT prolongation
Monitoring
ECG, parasite count
Pregnancy and breastfeeding
Acceptable in second and third trimester
Renal and hepatic impairment
Caution in severe hepatic or renal impairment
Overdose and reversal
Supportive
Special advice
Take with fatty food; check ECG in cardiac risk.
More from the textbook: uses, cautions and other points
- Uncomplicated falciparum malaria - oral artemether–lumefantrine (Riamet -6 doses over 3 days, taken with fatty food) or atovaquone–proguanil (Malarone -4 tablets once daily for 3 days, with food); quinine plus doxycycline or clindamycin is an alternative. Don't use the drug the patient took as prophylaxis.
ID: Tropical and travel medicine - Uncomplicated falciparum - artemisinin combination therapy (artemether–lumefantrine - Riamet - or dihydroartemisinin–piperaquine) or atovaquone–proguanil; usually admitted.
Microbiology: Fungi, parasites and travel-related infection
Where it is discussed in the book
- ID: Tropical and travel medicine (1 mention)
- Microbiology: Fungi, parasites and travel-related infection (1 mention)